Home > List All Publishers > CHI Insight Pharma Reports

CHI Insight Pharma Reports

CHA Advances Reports are a service of Cambridge Healthtech Advisors. Advances Reports are written by experts who collaborate with CHA to provide a series of reports that evaluate the salient trends in pharmaceutical technology, business, and therapy markets.

Advances Reports offer:

Current information and analysis of R&D technologies, therapeutic markets, and critical business issues.

Analysis of the probability of success for various applications of each technology.

Interviews with key personnel in companies at the forefront of technological advances.

Competitive insight on the business strategies and activities of key companies.

List of reports from CHI Insight Pharma Reports

The Impact of iPads on Pharma: a Primer 7/1/2011 \| published by: CHI Insight Pharma Reports ... Pharma is still being measured, but for an industry notoriously reluctant to adopt new technology, there is no doubt the iPad and tablets in general have changed the game. Already, major players such as Pfizer, ... \| more...	$295.00
Pharma on Twitter: Developing a Presence 6/1/2011 \| published by: CHI Insight Pharma Reports ... from corporate tweeters on how and why pharmaceutical companies are using this medium as a communications tool. In the five years since GlaxoSmithKline set up the first industry corporate Twitter account, more than 130 pharmaceutical ... \| more...	$395.00
Cancer Vaccines Market Study 1/1/2012 \| published by: CHI Insight Pharma Reports ... cancer vaccines, which was designed to focus on standardized immunogenic vaccines vs. autologous cell therapies or passive immunotherapies. Included in this 20 page Industry Market Study is Expert Interviews, Market Data, Analysis and Survey Results. \| more...	$495.00
Pharma Blogging: Speaking Out 3/1/2011 \| published by: CHI Insight Pharma Reports ... manner than traditional media channels have allowed. Pharma blogs also provide companies with the means of expressing their own opinions on stories that concern them, as well as presenting the possibility of entering into a ... \| more...	$495.00
Pharmaceutical Brand PR:Developing Engaging Campaigns and Measuring ROI 9/1/2011 \| published by: CHI Insight Pharma Reports ... increase—in part due to social media—its role is broadening. A trend towards using key performance indicators to measure previously difficult-to-define notions of success is emerging. Report OverviewIn Pharmaceutical Brand PR: Developing Engaging Campaigns and Measuring ... \| more...	$495.00
Digital Marketing Talent: Who Is Pharma Hiring? 8/1/2011 \| published by: CHI Insight Pharma Reports ... many companies are responding to the increasing importance of digital technology and problem-solving with the development of new jobs and titles. With new positions such as 'social media and community management' and 'mobile marketing and ... \| more...	$495.00
Next-Generation Mass Spectrometry: Technology Advances and Applications 7/1/2011 \| published by: CHI Insight Pharma Reports ... of data in the medical sciences that brings new insights into critical questions. This report analyzes: Physical principles and analytical applications of mass spectrometry The role of mass spectrometry in genomics, proteomics, metabolomics, and lipidomics ... \| more...	$595.00
Pharma Marketing Excellence: Lessons from Experience 8/1/2011 \| published by: CHI Insight Pharma Reports ... excellence programmes have been developed and implemented with an eye to overcoming those hurdles. But how well are they working and is there one optimal model for their use? There is no question that such ... \| more...	$595.00
Kinase-Targeted Therapeutics: Development Pipelines, Challenges, and Opportunities 8/1/2011 \| published by: CHI Insight Pharma Reports ... clinical evaluation. Kinases make up a veritable treasure trove of targets for a variety of indications. This report analyzes: The considerable array of therapeutic development efforts directed at kinases Current and emerging technologies being applied ... \| more...	$595.00
Keys for Pharma Success: Integrating Social 5/1/2011 \| published by: CHI Insight Pharma Reports ... and YouTube presences. In the course of developing these activities, and in the absence of explicit FDA or local regulatory guidance, Pharma has endeavoured to remain in compliance whilst formulating social media governance and establishing ... \| more...	$595.00
Fragment-Based Drug Discovery: Technologies, Applications, and Pipelines - Overview 4/1/2012 \| published by: CHI Insight Pharma Reports ... Drug Discovery: Technologies, Applications, and Pipelines, examines the many issues that must be considered vis-à-vis employment of fragment-based screening approaches. Chemical considerations are examined, including the impact of high-throughput screening (HTS) and its attendant shortcomings, ... \| more...	$795.00
Autoimmune Diseases: Pipelines for Crohn's Disease, Multiple Sclerosis and Rheumatoid Arthritis 6/1/2011 \| published by: CHI Insight Pharma Reports ... targets are actively being investigated and what new targets are coming forward? Who has candidates in active Phase III and Phase II clinical trials? What does the overall target activity map, from launched drug to ... \| more...	$795.00
Epigenetics: Technologies, Applications, and the Commercial Landscape 2/1/2008 \| published by: CHI Insight Pharma Reports ... applications An epigenetic approach to cancer etiology The epigenetics of noncancerous diseases DNA methylation and histone modifications as biomarkers The companies involved and their products Epigenetic therapeutics: demethylating agents, histone modifications, and combinations The drivers ... \| more...	$1,498.00
Outlook for DNA Microarrays: Emerging Applications and Insights on Optimizing Microarray Studies 7/1/2002 \| published by: CHI Insight Pharma Reports ... pure research applications toward the clinic. New tools and approaches for microarray analysis. The DNA microarray marketplace is changing rapidly. Microarrays are already widely adopted, and many use2rs are now going beyond exploratory studies. With ... \| more... Search inside this report	$1,500.00
Toxicogenomics and Related Approaches: The Promise of Safer, Smarter Drug Development 5/15/2002 \| published by: CHI Insight Pharma Reports ... expression patterns in target cells or tissues, is emerging as a key approach in screening new drug candidates because it may reveal genetic signatures that can be used to predict toxicity in these compounds. This ... \| more... Search inside this report	$1,500.00
Biochemical Pathway and Systems Analysis for Target Identification and Validation 4/1/2002 \| published by: CHI Insight Pharma Reports ... numerous drug discovery researchers and is central to the strategy of many biopharmaceutical and genomic companies. Biochemical Pathway and Systems Analysis for Target Identification and Validation examines various types of biochemical pathways, including metabolic and ... \| more... Search inside this report	$1,500.00
High-Content Screening: Parallel Analysis Fuels Accelerated Discovery and Development 8/1/2002 \| published by: CHI Insight Pharma Reports ... to the traditional drug discovery process. Given the high cost of failure in drug development, it is crucial that researchers have tools that provide high-quality information about drug targets. High-Content Screening: Parallel Analysis Fuels Accelerated ... \| more... Search inside this report	$1,500.00
Life Science Informatics: From Data to Drugs 4/1/2003 \| published by: CHI Insight Pharma Reports ... particular, has gone through a dramatic boom/bust. At the same time, a large number of IT companies are looking to the drug discovery and development arena as a new market opportunity. Pharmaceutical companies, meanwhile, are ... \| more... Search inside this report	$1,500.00
Advances in Lead Optimization Accelerating Drug Discovery and Development 2/1/2003 \| published by: CHI Insight Pharma Reports ... cost of drug discovery and development, a major shift is occurring in how pharmaceutical companies evaluate drug leads. Whereas researchers used to begin by looking at affinity and potency, a genomics/informatics-based research culture is growing ... \| more... Search inside this report	$1,500.00
Prospects for the Commercialization of Human Monoclonal Antibodies 12/1/2002 \| published by: CHI Insight Pharma Reports ... with a wealth of targets and a desire to reap the benefits of developing their own drugs are partnering with major antibody developers, as well as smaller companies that can convert those targets into potential ... \| more... Search inside this report	$1,500.00
Targeting RNA in Drug Development: Emerging Tools and Therapeutics 12/1/2002 \| published by: CHI Insight Pharma Reports ... pharmaceutical industry. RNA's ability to down- or up-regulate gene expression, interfere with protein function, and provoke immune responses has stirred interest and accelerated an ever-increasing number of products into the pipeline. Numerous challenges remain, including ... \| more... Search inside this report	$1,500.00
High-Content Analysis: Technologies, Applications, and Market Dynamics 12/1/2011 \| published by: CHI Insight Pharma Reports ... of “industrialized drug discovery.” This report discusses: Development of the HCA field from the commercial, scientific, and technological perspectives Technologies that underlie HCA and the full range of systems that are available today Applications of ... \| more...	$1,795.00
Cancer Genomics: Revolutionizing Treatment and Reshaping Markets through Targeted Therapies 8/1/2003 \| published by: CHI Insight Pharma Reports ... strongly by genomics and related technologies than any other indication area. Cancer arises from genetic changes in cells and hence, the availability of tools to better understand exactly how this occurs is revolutionizing the field. ... \| more... Search inside this report	$2,150.00
Proteins: Selection, Synthesis, and Purification Strategies for Optimizing Drug Discovery 1/1/2004 \| published by: CHI Insight Pharma Reports ... the key to understanding of basic biological processes including disease pathology, diagnosis, and treatment. Proteomics will undoubtedly have a profound impact on the drug discovery and development process. The pervasiveness of protein function and their ... \| more... Search inside this report	$2,150.00
Molecular Diagnostics: Technological Advances Fueling Market Expansion 10/1/2003 \| published by: CHI Insight Pharma Reports ... field. The report examines the clinical applications for molecular diagnostics, reviews the breadth of technologies now used or in development, evaluates the major players in this market, and discusses the business and health care implications ... \| more... Search inside this report	$2,150.00

< prev 1 2 3 4 5 6 next >